Biomerieux SA - Unsponsored ADR logo

Biomerieux SA - Unsponsored ADR (BMXXY)

Market Open
11 Jun, 20:00
OTC PINK OTC PINK
$
8. 00
-0.03
-0.3736%
$
9.47B Market Cap
34.75 P/E Ratio
0.41% Div Yield
200 Volume
4.09 Eps
$ 8.03
Previous Close
Add Transaction
Day Range
8 8.43
Year Range
7.91 14.62
Want to track BMXXY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BMXXY trading today lower at $8, a decrease of -0.3736% from yesterday's close, completing a monthly increase of 0.6289% or $0.05. Over the past 12 months, BMXXY stock lost -36.5079%.
The next announced payment will be in In 2 weeks on Jun 26, 2026 for a total of $0.1138.
The last earnings report, released on Mar 05, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

BMXXY Chart

People also search for

Aisin Corporation
$ 14.25
+4.7794%
Niterra Co., Ltd. Unsponsored ADR
$ 25
0%
Shoprite Holdings Ltd Sponsored ADR
$ 18.05
+2.7319%
Brenntag SE
$ 13.03
+2.3566%
Isuzu Motors Ltd. Unsponsored ADR
$ 13.18
-0.4532%

Biomerieux SA - Unsponsored ADR (BMXXY) FAQ

What is the stock price today?

The current price is $8.00.

On which exchange is it traded?

Biomerieux SA - Unsponsored ADR is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is BMXXY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.41%.

What is its market cap?

As of today, the market cap is 9.47B.

Has Biomerieux SA - Unsponsored ADR ever had a stock split?

No, there has never been a stock split.

Biomerieux SA - Unsponsored ADR Profile

Household Durables Industry
Consumer Discretionary Sector
Pierre Boulud CEO
OTC PINK Exchange
09074E101 CUSIP
FR Country
14,147 Employees
10 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

bioMérieux S.A., originally known as B-D Mérieux, is a pioneering entity in the field of in vitro diagnostic solutions, standing at the forefront since its inception in 1963. With its headquarters nestled in Marcy l'Etoile, France, the company stretches its influence globally, catering to diverse regions including the Americas, Europe, the Middle East, Africa, and the Asia Pacific. As a subsidiary of Institut Mérieux SA, bioMérieux has carved a niche in diagnosing infectious diseases through advanced diagnostic systems that leverage biological samples such as blood, saliva, and urine. These systems are adept at identifying a broad spectrum of infectious diseases, ranging from bacterial, parasitic to viral infections, thereby facilitating timely and accurate medical interventions.

Apart from its clinical applications, bioMérieux is instrumental in ensuring the microbiological integrity of production environments across the food, pharmaceutical, and cosmetic industries. The company's commitment to innovation is further exemplified through its BIOMÉRIEUX VISION SUITE, a comprehensive suite of software products and services designed for the seamless collection, analysis, and integration of diverse data sources to aid in decisive actions. Furthermore, bioMérieux's extensive portfolio includes designing, manufacturing, and maintaining sophisticated instruments and software, alongside a vast array of reagents for in vitro diagnostic tests, addressing the needs of clinical and hospital laboratories, physicians, blood banks, veterinarians, and industrial control laboratories.

Products and Services

  • Diagnostic Solutions for Infectious Diseases: Utilizing biological samples, these advanced systems diagnose a variety of infectious diseases. From bacterial to viral and parasitic infections, bioMérieux provides critical insights for healthcare providers.
  • Microbiological Control for Industries: Ensuring the safety and quality of products in the food, pharmaceutical, and cosmetic industries, bioMérieux's solutions monitor and validate the microbiological status of production processes and environments.
  • BIOMÉRIEUX VISION SUITE: An integrated suite of software that gathers, analyzes, and combines different data sources. This powerful tool supports decision-making processes, particularly in the management and interpretation of diagnostic tests.
  • Instruments and Software Design and Maintenance: bioMérieux excels in the creation and upkeep of high-quality instruments and software, providing reliable and efficient solutions for diagnostics and beyond.
  • Reagents for in vitro Diagnostics: A comprehensive range of reagents is designed and manufactured by bioMérieux, catering to the diverse needs of diagnostic tests across various medical and industrial fields.

Contact Information

Address: 376 Chemin De l’Orme
Phone: 33 4 78 87 20 00